FHIR © HL7.org | Server Home | FHIR Server FHIR Server 3.7.22-SNAPSHOT | FHIR Version n/a User: [n/a]

326121004: Product containing precisely dinoprostone 3 milligram/1 each conventional release vaginal tablet (clinical drug)

SNOMED CT Concept\Pharmaceutical / biologic product (product)\Medicinal product (product)\...

\Medicinal product categorized by structure\Product containing organic acid and/or organic acid derivative (product)\Carboxylic acid and/or carboxylic acid derivative-containing product\Product containing prostaglandin (product)\Product containing E series prostaglandin (product)\Product containing dinoprostone (medicinal product)\...

\Dinoprostone only product\Dinoprostone only product in vaginal dose form\Dinoprostone 3 mg vaginal tablet

\Dinoprostone-containing product in vaginal dose form\Dinoprostone only product in vaginal dose form\Dinoprostone 3 mg vaginal tablet

\Product manufactured as vaginal dose form (product)\Dinoprostone-containing product in vaginal dose form\Dinoprostone only product in vaginal dose form\Dinoprostone 3 mg vaginal tablet

Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

3674337017 Dinoprostone 3 mg vaginal tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

3674338010 Product containing precisely dinoprostone 3 milligram/1 each conventional release vaginal tablet (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Dinoprostone 3 mg vaginal tablet	Is a	Dinoprostone-containing product in vaginal dose form	false	Inferred relationship	Some
Dinoprostone 3 mg vaginal tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	Prostaglandin PGE>2<	false	Inferred relationship	Some
Dinoprostone 3 mg vaginal tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	Prostaglandin E>1<	false	Inferred relationship	Some
Dinoprostone 3 mg vaginal tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	Dinoprostone (substance)	false	Inferred relationship	Some
Dinoprostone 3 mg vaginal tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	Posterior pituitary hormone	false	Inferred relationship	Some
Dinoprostone 3 mg vaginal tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	Alprostadil	false	Inferred relationship	Some
Dinoprostone 3 mg vaginal tablet	Has manufactured dose form	Vaginal dose form (dose form)	false	Inferred relationship	Some
Dinoprostone 3 mg vaginal tablet	Has manufactured dose form	Vaginal tablet	true	Inferred relationship	Some
Dinoprostone 3 mg vaginal tablet	Has presentation strength denominator value	un	false	Inferred relationship	Some	1
Dinoprostone 3 mg vaginal tablet	This attribute specifies the numerator unit for the presentation strength of a product.	mg	true	Inferred relationship	Some	1
Dinoprostone 3 mg vaginal tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	Dinoprostone (substance)	true	Inferred relationship	Some	1
Dinoprostone 3 mg vaginal tablet	Has presentation strength numerator value	trois	false	Inferred relationship	Some	1
Dinoprostone 3 mg vaginal tablet	Has unit of presentation	Tablet (unit of presentation)	true	Inferred relationship	Some
Dinoprostone 3 mg vaginal tablet	This attribute specifies the denominator unit for the presentation strength of a product.	Tablet (unit of presentation)	true	Inferred relationship	Some	1
Dinoprostone 3 mg vaginal tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	Dinoprostone (substance)	true	Inferred relationship	Some	1
Dinoprostone 3 mg vaginal tablet	Count of base of active ingredient	un	false	Inferred relationship	Some
Dinoprostone 3 mg vaginal tablet	Is a	Dinoprostone only product in vaginal dose form	true	Inferred relationship	Some
Dinoprostone 3 mg vaginal tablet	Plays role	Oxytocic therapeutic role (role)	false	Inferred relationship	Some

Inbound Relationships

Type

Active

Source

Characteristic

Refinability

Group

Reference Sets

GB English

US English

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
3674337017	Dinoprostone 3 mg vaginal tablet	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
3674338010	Product containing precisely dinoprostone 3 milligram/1 each conventional release vaginal tablet (clinical drug)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core